PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.610
+0.040 (2.55%)
Nov 21, 2024, 4:00 PM EST - Market closed
PMV Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 83 | 159 | 397 | 1,048 | 2,754 | - | |
| Market Cap Growth | -74.20% | -60.08% | -62.10% | -61.94% | - | - | |
| Enterprise Value | -103 | -67 | 151 | 733 | 2,381 | - | |
| Last Close Price | 1.57 | 3.10 | 8.70 | 23.10 | 61.51 | - | |
| PB Ratio | 0.41 | 0.70 | 1.61 | 3.40 | 7.67 | - | |
| P/TBV Ratio | 0.39 | 0.70 | 1.61 | 3.40 | 7.67 | - | |
| Debt / Equity Ratio | 0.07 | 0.06 | 0.06 | 0.04 | - | - | |
| Quick Ratio | 13.48 | 14.47 | 22.25 | 24.32 | 56.38 | 22.44 | |
| Current Ratio | 13.98 | 14.78 | 22.80 | 24.66 | 56.90 | 22.57 | |
| Return on Equity (ROE) | -23.63% | -29.24% | -26.44% | -17.33% | -15.05% | -31.78% | |
| Return on Assets (ROA) | -20.27% | -19.17% | -16.00% | -10.45% | -9.32% | -20.00% | |
| Return on Capital (ROIC) | -21.29% | -20.07% | -16.61% | -10.73% | -9.55% | -20.87% | |
| Earnings Yield | -61.97% | -43.48% | -18.45% | -5.52% | -1.25% | - | |
| FCF Yield | -57.19% | -35.70% | -18.06% | -4.57% | -1.19% | - | |
| Buyback Yield / Dilution | -10.47% | -5.31% | -1.01% | -214.23% | -373.26% | -0.76% | |
| Total Shareholder Return | -10.47% | -5.31% | -1.01% | -214.23% | -373.26% | -0.76% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.